THERAPY AND PREVENTION AORTITIS Percutaneous transluminal balloon angioplasty of the aorta in patients with aortitis
نویسنده
چکیده
Four patients with aortitis and stenotic lesions of the aorta were successfully treated by percutaneous transluminal balloon angioplasty. The peak systolic gradient across the constrictions decreased from 82.5 ± 35.7 to 37.5 ± 18.5 mm Hg immediately after dilatation. Repeat angiography in the first three patients performed 2 months later showed a further decrease in the gradient to 13.8 + 9.5 mm Hg. There were no complications during or after the procedure, and all the patients have shown remarkable symptomatic relief during the follow-up. Circulation 76, No. 3, 597-600, 1987. AORTITIS is a form of vasculitis with the characteristic feature of "pulselessness."1 The inflammatory process commonly involves the aorta and its major branches. Its clinical manifestations are variable depending on the regional distribution of the disease, the type of vascular lesions, and whether the inflammation is persistent or has resolved. The etiology is still uncertain. Specific treatment of the disease is not available without knowledge of the exact etiology. Surgical treatment is used during the chronic phase to deal with late complications of aortitis, but the scope of surgical therapy is limited because of the multifocal and often progressive nature of the disease. After the introduction of percutaneous transluminal balloon angioplasty in 1964 by Dotter and Judkins2 and the development of the balloon dilatation catheter in 1974 by Griintzig and Hopff,3 percutaneous transluminal balloon angioplasty has become an accepted mode of treatment for stenotic lesions. Successful dilatation of coarctation of the aorta,4 5 restenosis of coarctation,6 atherosclerotic stenosis of the lower abdominal aorta,7 8 and peripheral arteries has been reported.19 Experience with balloon dilatation angioplasty in aortitis is very limited. To our knowledge, only four cases of balloon angioplasty in this setting have been reported. 12-14 Here we report for the first time four cases in which successful dilatation of aortic From the Department of Cardiology, G. B. Pant Hospital, New Delhi, India. Address for correspondence: Dr. M. Khalilullah, Department of Cardiology, G. B. Pant Hospital, New Delhi 110 002, India. Received Dec. 12, 1986; revision accepted April 23, 1987. Vol. 76, No. 3, September 1987 constrictions has been perfonned in patients with
منابع مشابه
THERAPY AND PREVENTION CONGENITAL HEART DISEASE Balloon dilatation angioplasty: nonsurgical management of coarctation of the aorta
Balloon dilatation angioplasty was successfully performed in five patients (ages 18 months to 17 years) with discrete aortic coarctation. The catheter size was No. 8F or 9F. Selection of balloon diameter was based on angiographic measurements of the aorta determined proximal and distal to the coarctation site. A 10 sec inflation-deflation cycle at 6 to 8 atmospheres (90 to 120 psi) was performe...
متن کاملTHERAPY AND PREVENTION CONGENITAL HEART DISEASE Treatment of restenosis of coarctation by percutaneous transluminal angioplasty
Percutaneous transluminal angioplasty (PTA) was used successfully to treat coarctation restenosis in seven patients. The patients were 10 months to 17 years old at the time of the angioplasty, and the initial coarctation repair had been performed 10 months to 161⁄2/2 years previously. PTA reduced the systolic pressure gradient across the coarctation from a mean of 58 mm Hg before the procedure ...
متن کاملDoes the New Angiotensin Converting Enzyme Inhibitor Cilazapril Prevent Restenosis After Percutaneous Transluminal Coronary Angioplast? Results of the MERCATOR Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial
Background. Cilazapril is a novel angiotensin converting enzyme inhibitor with antiproliferative effects in the rat model after balloon injury. Methods and Results. We conducted a randomized, double-blind placebo-controlled trial to assess the effect of cilazapril in angiographic restenosis prevention after percutaneous transluminal coronary angioplasty (PTCA). Patients received cilazapril 2.5 ...
متن کاملTHERAPY AND PREVENTION CORONARY ARTERY DISEASE Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study
To determine the influence of adjunctive treatment with coumadin or aspirin on recurrence rate after percutaneous transluminal coronary angioplasty (PTCA), 248 patients in whom PTCA was assessed to be a primary success were randomized to either 325 mm aspirin daily or to coumadin treatment sufficient to maintain a prothrombin time 2 to 2.5 times the control value. The follow-up protocol include...
متن کاملDoes the New Angiotensin Converting Enzyme Inhibitor Cilazapril Prevent Restenosis After Percutaneous Transluminal Coronary Angioplast? Results of the MERCATOR Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial
Background. Cilazapril is a novel angiotensin converting enzyme inhibitor with antiproliferative effects in the rat model after balloon injury. Methods and Results. We conducted a randomized, double-blind placebo-controlled trial to assess the effect of cilazapril in angiographic restenosis prevention after percutaneous transluminal coronary angioplasty (PTCA). Patients received cilazapril 2.5 ...
متن کامل